Day One - Wednesday May 8th

Time Topic
9.00am
Opening Panel Session:
Obamacare and the ACA: the impact on the oncology manufacturers
  • Loreen Brown, Senior Vice President, Xcenda
  • Liz Cirri, Associate Vice President, Government Reimbursement, Sanofi US
  • Jay Seemann, Senior Director of US Market Access & Reimbursement, Onyx
10.00am
Integrate market access across commercial functions
  • Sasha Richardson, Vice President, Market Access, GfK Custom Research
10.35am
Coffee
11.15am
Understand stakeholder perspectives on quality of care and learn to collaborate for product success
  • Don Sharpe, Editor, Oncology Business Review
  • Paul G. Pochtar RPh., Vice President; Payer Marketing, Bayer Healthcare Pharmaceuticals
11.50am
How biosimilars will affect you and your product strategy
  • Dana Evans, Director, Medical Affairs Payer Support, Genentech
12.25pm
Lunch
1.30pm
Connect the dots and achieve cross-functional cooperation
  • Suraj Moorthy, Senior Director, Global Forecasting, EMD Serono (formerly Sr Commercial Expert, Global Strategy & Portfolio Management, Sanofi Oncology)
2.05pm
Oncology medical home as a vehicle for risk and cost reduction
  • Steven L. D'Amato, Executive Director Clinical Pharmacy Specialist, Maine Center for Cancer Medicine
2.40pm
What factors determine optimal site of patient care?
  • Christian Downs, Executive Director, Association Community Cancer Centers
  • TBC, Eli Lilly
3.15pm
Coffee
3.45pm
Exchanges, ACOs and the impact on oncology care & oncology decision making post-2014
  • Mr. Matthew Farber, VP, Federal Policy, Association of Community Cancer Centers
4.20pm
The fallacy of emerging models: preserve community oncology by supporting buy and bill
  • Barry Fortner, Ph.D., Senior Vice President, Operations, ION Solutions
4.55pm
Panel Session:
C-Suite pathways panel
  • Dr. Bruce Feinberg, Chief Medical Officer, Cardinal Health
  • Kathy Lokay, CEO, D3 Oncology Solutions
  • C. Lyn Fitzgerald, Vice President, US and Global Development, NCCN
  • Dr. Atul Dhir, CEO, New Century Health
5.45pm
Networking Drinks & Dinner
Get the full picture - download the brochure
Download Now

Day Two - Thursday May 9th

Market Access & Marketing Masterclass

Time Topic
9.00am
Personalized medicine: biomarkers, diagnostics and physician/payer adoption in an ever-changing reimbursement climate
  • Laura Housman, Vice President, Market Access, Pricing, HE&OR, Novartis - Genoptix
9.35am
Work with your stakeholders to achieve market access
  • Melinda C. Haren, Director of Access Strategies, The Zitter Group
10.10am
Payer perspective on the value of innovation in an increasingly crowded marketplace
  • Dr. Ira Klein, Chief of Staff to the CMO, Aetna
10.45am
Coffee
11.15am
Deliver a new oncology customer experience: maintain access and relevance to Oncologists even when they're shutting their doors
  • Jon Roffman, Associate Principal and Leader, Oncology Field Force Strategy Practice, ZS Associates
11.50am
Optimizing Rx Value with Dx
  • Charles Mathews, Vice President, Boston Healthcare
12.25pm
Lunch
1.30pm
Payer perspectives prior to phase 3: endpoints, quality measures and RWE
  • Yanni Hao, Director of Market Access, Janssen
2.05pm
Marketing for targeted therapies
  • Darren Cline, Vice President, Marketing, Managed Markets and Reimbursement, Seattle Genetics
2.40pm
Collaborate with diagnostic developers to achieve personalized Marketing
  • Jerry Conway, Vice President, Reimbursement & Payer Strategy, Foundation Medicine
3.05pm
Close
Get the full picture - download the brochure
Download Now

Global Sponsors

Gold Sponsors